Perceptive Informatics
today announced that it is bringing further advancements to its eClinical platform. Perceptive has incorporated IBM’s WebSphere® portal and Tivoli® Access Manager into its eClinical platform, which provides support for its
eClinical Suite
.
Powered by foundational technologies that enable applications within its eClinical Suite, Perceptive’s eClinical platform incorporates reporting, integration, and identity management solutions, among others. The platform technologies from IBM allow Perceptive to support more extensive interoperability between its systems and facilitate a single entry point for users. The technologies also provide support for Perceptive’s eClinical solutions offered as Software-as-a-Service (SaaS) applications, which are developed to be hosted by Perceptive.
“As the number of technologies used in clinical trials increases, Perceptive is committed to expanding our robust and flexible enterprise platform to meet customer demand for innovative, sophisticated, and easily accessible eClinical solutions,” said Nicholas Richards, Vice President, Product Development, Perceptive Informatics.
IBM’s WebSphere portal framework enhances the Perceptive Portal enterprise solution, which provides secure, centralized access to clinical trial documentation and training materials as well as a collaboration area to develop related materials. The portal’s reporting engine displays consolidated trial metrics, allowing study performance to be easily tracked using data drawn from multiple sources. Perceptive has incorporated IBM’s Tivoli Access Manager to improve single sign-on functionality. Designed to streamline workflow, this advancement eliminates the need for multiple user names and passwords by providing access to various systems with one set of credentials.
The eClinical Suite from Perceptive Informatics provides advanced integration and interoperability among systems, including the IMPACT® Clinical Trial Management System (CTMS), the DataLabs® EDC solution, and the ClinPhone® Randomization and Trial Supply Management (RTSM) technologies. The suite supports real-time data interchange and enables diverse applications to work synergistically. For more information about Perceptive’s eClinical Suite visit:
http://www.perceptive.com/Solutions/eClinical-Suite.html
.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.